Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether compared with arsenic trioxide TACE alone,
arsenic trioxide TACE and intravenous administration could further prolong the overall
survival.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Guangdong General Hospital Guangdong Provincial People's Hospital